[1]
Gilibili, R.R. et al. 2015. Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles – Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and Vildagliptin. Journal of Pharmacy & Pharmaceutical Sciences. 18, 3 (Sep. 2015), 434–447. DOI:https://doi.org/10.18433/J3TK55.